Stockreport

Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

Satellos Bioscience Inc.  (MSLE) 
PDF Completed a US$57.2 million equity financing; commenced trading on the Nasdaq Global Market under the ticker “MSLE” on Feb. 6, 2026 Secured global regulatory clearances [Read more]